tiprankstipranks
Bioventix PLC (GB:BVXP)
LSE:BVXP

Bioventix (BVXP) Price & Analysis

Compare
7 Followers

BVXP Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

0.02%99.98%
Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors

BVXP FAQ

What was Bioventix PLC’s price range in the past 12 months?
Bioventix PLC lowest share price was 2552.00p and its highest was 4800.00p in the past 12 months.
    What is Bioventix PLC’s market cap?
    Bioventix PLC’s market cap is £143.54M.
      When is Bioventix PLC’s upcoming earnings report date?
      Bioventix PLC’s upcoming earnings report date is Mar 31, 2025 which is 2 days ago.
        How were Bioventix PLC’s earnings last quarter?
        Bioventix PLC released its earnings results on Mar 31, 2025. The company reported 0.712p earnings per share for the quarter, beating the consensus estimate of N/A by 0.712p.
          Is Bioventix PLC overvalued?
          According to Wall Street analysts Bioventix PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Bioventix PLC pay dividends?
            Bioventix PLC pays a Annually dividend of 87p which represents an annual dividend yield of 5.64%. See more information on Bioventix PLC dividends here
              What is Bioventix PLC’s EPS estimate?
              Bioventix PLC’s EPS estimate is 71.
                How many shares outstanding does Bioventix PLC have?
                Bioventix PLC has 5,219,656 shares outstanding.
                  What happened to Bioventix PLC’s price movement after its last earnings report?
                  Bioventix PLC reported an EPS of 0.712p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -10.345%.
                    Which hedge fund is a major shareholder of Bioventix PLC?
                    Currently, no hedge funds are holding shares in GB:BVXP
                    ---

                    Company Description

                    Bioventix PLC

                    Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.
                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    CML Microsystems
                    Oilex Ltd
                    Genuit Group
                    Proteome Sciences
                    Hansard Global
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis